High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.
Also called NCT03079115
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 130 participants
- Sponsor
- Beijing Hospital
- Registry
-
NCT03079115
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03079115. Randomized; single masking; primary purpose treatment. Start 2017-08-21 (actual); primary completion 2020-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting
- Acronym
- PICAS
- Condition
- Carotid Artery Stenosis
- Intervention (Drug)
- High-dose Atorvastatin
- Intervention (Drug)
- Conventional-dose Atorvastatin
- Lead sponsor
- Beijing Hospital
Record details
- Record id
cardio:ct-nct03079115- Content hash
391cee25d2f09597af712b5226eab084585c3ae06d7da3e22499bd3f1b1accd2